Athersys
ATHX
#10720
Rank
โ‚ฌ0.71 M
Marketcap
0,01161ย โ‚ฌ
Share price
-33.50%
Change (1 day)
-98.94%
Change (1 year)

EPS for Athersys (ATHX)

EPS in 2023 (TTM): -1,88ย โ‚ฌ

According to Athersys's latest financial reports the company's current EPS (TTM) is -1,75ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -5,61ย โ‚ฌ a decrease over its 2021 EPS that were of -1,79ย โ‚ฌ.

EPS history for Athersys from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,88ย โ‚ฌ-66.53%
2022-5,61ย โ‚ฌ213.94%
2021-1,79ย โ‚ฌ395.24%
2020-0,36ย โ‚ฌ44.83%
2019-0,25ย โ‚ฌ61.11%
2018-0,15ย โ‚ฌ-37.93%
2017-0,25ย โ‚ฌ70.59%
2016-0,15ย โ‚ฌ-19.05%
2015-0,18ย โ‚ฌ-25%
2014-0,24ย โ‚ฌ
2012-0,42ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,51ย โ‚ฌ-530.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,13ย โ‚ฌ-164.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
12,45ย โ‚ฌ-813.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2,20ย โ‚ฌ-226.09%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
3,06ย โ‚ฌ-275.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
3,06ย โ‚ฌ-275.37%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
3,93ย โ‚ฌ-325.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-7,01ย โ‚ฌ 301.48%๐Ÿ‡บ๐Ÿ‡ธ USA